Oxybutynin Chloride in Managing Hot Flashes

NCT02961790 PHASE3 COMPLETED Results posted

This randomized phase III trial studies how well oxybutynin chloride works in managing hot flashes in patients who are not candidates for, or not interested in hormone replacement therapy. Previous studies have shown that oxybutynin is effective in managing hot flashes, however doses used in prior studies have resulted in side effects. This trial is evaluating lower doses of oxybutynin with the goal of determining if they are efficacious with less side effects. ADAM-VTE

Details

Lead sponsor	Academic and Community Cancer Research United
Phase	PHASE3
Status	COMPLETED
Enrolment	150
Start date	Fri Dec 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Apr 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Breast Carcinoma
• Ductal Breast Carcinoma In Situ
• Hot Flashes
• Lobular Breast Carcinoma In Situ
• No Evidence of Disease

Interventions

• Oxybutynin Chloride
• Placebo
• Quality-of-Life Assessment
• Questionnaire Administration

Countries

United States